Gakken Holdings (9470) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 May, 2026Executive summary
Net sales rose 7.3% year-over-year to ¥199.1 billion, with operating profit up 19.7% to ¥8.23 billion and net profit up 58.3% to ¥3.58 billion, meeting profit targets and concluding the Gakken 2025 plan successfully.
Growth was driven by strong performance in Healthcare and Nursing, Publishing and Content, and consolidation of DTP Education Solutions JSC and Kirihara Shoten K.K.
Operating profit benefited from price revisions, cost reductions in Education, and recovery in Healthcare and Nursing in the second half.
Net profit surged due to step-acquisition gains, sale of cross-shareholdings, and absence of prior year losses, despite impairment losses.
Financial highlights
EBITDA increased 16.2% year-over-year to ¥12.97 billion, with EPS rising to ¥86.02 from ¥52.99.
Ordinary profit rose 13.1% year-over-year to ¥7.81 billion.
Comprehensive income reached ¥3.33 billion, up 39.9% year-over-year.
Cash and cash equivalents at period end were ¥20.99 billion, up ¥2.23 billion year-over-year.
Total assets increased 6.5% year-over-year to ¥139.1 billion, while equity-to-asset ratio declined to 36.9%.
Outlook and guidance
FY2026 forecast: Net sales ¥205 billion (+3.0% YoY), operating profit ¥8.5 billion (+3.2% YoY), net profit ¥4 billion (+11.8% YoY), EPS ¥96.77.
Focus on global expansion, especially in Southeast Asia, and strengthening recurrent education and reskilling initiatives.
Continued investment in growth domains and proactive M&A to build core revenue pillars.
Strategic shift toward enhancing business, financial, and organizational value through 2030.
Business expansion in Vietnam and continued development of elderly care facilities expected.
Latest events from Gakken Holdings
- Operating profit surged 56% YoY on strong education, healthcare, and subsidiary growth.9470
Q3 202413 May 2026 - Sales and profit grew, but net profit dropped on a one-time loss; FY2025 outlook is positive.9470
Q4 202413 May 2026 - Sales up 7.5% YoY, but profit margins pressured by rising costs; net profit rebounded.9470
Q1 202513 May 2026 - Sales up 5.7%, operating profit down on costs; net profit and outlook boosted by acquisitions.9470
Q2 202513 May 2026 - Net sales rose 6.2% YoY, but higher costs trimmed operating profit; profit outlook remains strong.9470
Q3 202513 May 2026 - Net sales and profits rose, but net profit declined due to one-time items and valuation losses.9470
Q1 202613 May 2026